Changes in hippocampal histamine receptors in rats after treatment with Trimeresurus albolabris venom

BACKGROUND： It has been demonstrated that histamine and its receptors in the hippocampus play an important role in memory and/or learning behaviors.OBJECTIVE： To investigate the expression levels of the histamine receptor gene and protein in the hippocampi of rats prior to and after administration of Trimeresurus albolabris venom using reverse transcription-polymerase chain reaction （RT-PCR） and Western blot techniques. DESIGN, TIME AND SETTING： A controlled observation based on cellular protein level was performed in the College of Life Sciences, Chongqing Normal University between March 2005 and April 2007. MATERIALS： Eighty adult male Sprague-Dawley rats were provided by the Laboratory Animal Center of the Third Military Medical University of Chinese PLA. The lyophilized powder of Trimeresurus albolabris venom was collected from Jin-Hu-Shan in Chongqing, China. METHODS： Twenty rats were randomly and evenly divided into an experimental group and a control group The experimental group was subcutaneously injected with 0.65 mg/mL Trimeresurus albolabris venom, 0.5 mL for each rat. The control group was subcutaneously injected with an equal amount of 0.9% physiological saline. Prior to and after injection, rats from these two groups were placed in the Morris Water Maze for recording of path length and escape latency. The remaining 60 rats were randomly allocated to another experimental group （n = 50） and another control group （n = 10）. Rats were correspondingly injected as described above. At different time points （0.1, 0.5, 1, 2, and 3 hours after injection）, rats were decapitated and bilateral hippocampal tissues were dissociated （approximately 100 mg for each sample）. Then, the acquired hippocampal tissue was immediately preserved at -70 ℃ for subsequent experiments. MAIN OUTCOME MEASURES： （1） The levels of histamine receptor （including H1R, H2R, and H3R） mRNA and protein in the hippocampi of rats were measured prior to and after injection of Trimeresurus albolabris venom using RT-PCR and Western Blot techniques. （2） Escape latency （namely, time to reach a platform） and path length were examined by Morris Water Maze testing. RESULTS： All 80 rats were included in the final analysis. In the experimental group, the level of mRNA for H3R receptor in rat hippocampi was just slightly changed, but the level of H3R receptor protein was significantly down-regulated compared with that in the control group （P 〈 0.05）. Both mRNA and protein levels for H1R receptor were initially downregulated and then recovered to normal levels. Expression of H2R receptor mRNA was initially upregulated, then downregulated, and finally restored to the control level. The level of H2R receptor protein showed a tendency for downregulation. In the Morris Water Maze testing, escape latency and path length were significantly longer in the experimental group than in the control group （P 〈 0.05）. CONCLUSION： Within three hours of injection with Trimeresurus albolabris venom, mRNA and protein levels of most histamine receptors in rat hippocampi were downregulated. Such changes possibly contribute to an impairment of memory and/or learning behaviors in rats following injection of Trimeresurus albolabris venom.

Anti-endotoxic shock effects of cyproheptadine in rats

OBJECTIVE: To investigate the antagonistic effect and mechanism of the effect of cyproheptadine (Cyp) on endotoxic shock in rats. METHODS: Endotoxic shock was produced in rats by i.v. injection of lipopolysaccharides (LPS) (5 mg/kg). Tumor necrosis factor (TNF(alpha)) mRNA expression was assessed by Northern blot. Plasma TNF(alpha) content was measured by radioimmunoassay. Plasma superoxide dismutase (SOD) activity and malondialdehyde (MDA) content were measured. The intracellular free calcium concentration ([Ca(2+)](i)) in single endothelial cells was determined by laser scanning confocal microscopy (LSCM). RESULTS: Cyp 5 mg/kg injected immediately after i.v. LPS raised the mean arterial blood pressure (MABP) of shocked rats and improved their 24 h survival rate. Meanwhile, Cyp markedly decreased TNF(alpha) mRNA levels in rat liver (18 +/- 10 vs. LPS + saline 38 +/- 10, P

抗组胺药物治疗变应性鼻炎的评价和使用建议

抗组胺药物在治疗变应性鼻炎（AR）及变应性哮喘方面具有不可替代的作用,但怎样发挥最佳效果又能避免副作用（中枢镇静、心脏毒性等）,变态反应学家、药理学家、国际组织、药物生产厂家都进行了不懈的努力,各种研究和探索为患者和医师带来了知识更新和切实利益。

血管运动性鼻炎

血管运动性鼻炎（vasomotor rhinitis,VMR）是非变应性鼻炎（nonallergic rhinitis,NAR）中最常见的一种临床类型,据推测影响着37%～61%的鼻炎患者。但术语VMR一直存在不少争议，有学者建议使用自主性鼻炎（autonomic rhinitis）来暗示它是由神经源性功能障碍引发的；《变应性鼻炎及其对哮喘的影响》（allergic rhinitis and its impact on asthma，ARIA）2008年版指南则倾向于使用特发性鼻炎（idiopathic rhinitis）替代VMR，突出其发病原因不明的特点。

变应性鼻炎治疗中口服抗组胺药物的地位

变应性鼻炎（AR）已成为了一个全球性的健康问题,发病率呈逐年增长趋势,其发病时可以影响患者的日常工作、生活及学习效率,WHO组织全球鼻科和变态反应科的学者编写了＂变应性鼻炎及其对哮喘的影响（Allergic rhinitis and its impact on asthma,ARIA）＂指南,

抗组胺药物的临床应用

组胺是变应性鼻炎（AR）发病机制中重要的炎症介质之一,通过与H1受体结合而实现其刺激平滑肌收缩、刺激腺体分泌、扩张血管和增加血管通透性等生物学作用。抗组胺药物治疗已有60年的历史,

变应性鼻炎的药物治疗

变应性鼻炎（AR）是一个全球性健康问题，全球发病率10％--40％，且患者人数仍在增加，影响日常生活、工作及学习，造成经济和健康上的沉重负担。AR是全身变态反应的一部分，中重度AR与哮喘控制不良相关，常年性AR患者中哮喘发病率较高，更引起了人们对AR诊治的关注。

抗组胺药物治疗变应性鼻炎

组胺（histamine）属于神经递质,通过已知4种类型的组胺受体,在免疫调节和炎性反应中发挥重要作用,是I型超敏反应的核心介质。H1受体拮抗剂（H1 receptor antagonists）现称H1抗组胺药物（H1 antihistamines）,是临床最为常用的药物之一,

新型抗组胺药物治疗变应性鼻炎

1变应性鼻炎与鼻塞症状变应性鼻炎（AR）是一种常见的变应性炎症疾病,全世界人口患病率为10%～25%,有些国家高达40%。中国大陆地区11个中心城市的电话问卷调查显示AR的平均患病率为11%[1]。鼻塞是AR的主要症状,也是患者认为最烦恼的症状。

变应性鼻炎的抗组胺药物治疗

变应性鼻炎（AR）是一个全球性健康问题,全球发病率达10%～40%,且患者人数仍在增加,影响日常生活、工作及学习,造成经济上的沉重负担。为此2001年世界卫生组织参与制定了＂变应性鼻炎及其对哮喘的影响（allergic rhinitis and its impact on asthma,ARIA）＂指南,

ARIA指南2010版对抗组胺药物评价和使用建议

变应性鼻炎（AR）是耳鼻咽喉科临床常见的疾病,以清涕、喷嚏、鼻痒及鼻塞等作为主要症状,患病率可高达10%～20%。AR几乎均存在于各年龄阶段人群[1],患者深受疾病困扰,承担一定的生活、工作、经济及家庭等生理心理压力,并且有发展成为哮喘的风险。

抗组胺药物在儿童变应性鼻炎中的应用

迄今变应性鼻炎（AR）已成为全球性健康问题,是儿童时期最常见的慢性病之一,可以严重影响儿童的生理、心理健康和生活质量,同时也给社会和家庭造成巨大的负担,部分国家（地区）儿童AR的患病率达40%,并呈继续上升趋势[1]。